EVH Evolent Health Inc

Price (delayed)

$19.43

Market cap

$1.69B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.01

Enterprise value

$1.75B

Highlights
The EPS rose by 25% YoY and by 24% QoQ
Evolent Health's net income has increased by 21% QoQ and by 21% YoY
The revenue has grown by 14% YoY but it has contracted by 3.2% from the previous quarter
The company's equity fell by 27% YoY

Key stats

What are the main financial stats of EVH
Market
Shares outstanding
86.93M
Market cap
$1.69B
Enterprise value
$1.75B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.71
Price to sales (P/S)
1.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.77
Earnings
Revenue
$990.22M
EBIT
-$240.12M
EBITDA
-$179.44M
Free cash flow
-$71.86M
Per share
EPS
-$3.01
Free cash flow per share
-$0.85
Book value per share
$7.17
Revenue per share
$11.7
TBVPS
$8.23
Balance sheet
Total assets
$1.31B
Total liabilities
$688.29M
Debt
$296.57M
Equity
$617.3M
Working capital
$93.8M
Liquidity
Debt to equity
0.48
Current ratio
1.23
Quick ratio
1.15
Net debt/EBITDA
-0.34
Margins
EBITDA margin
-18.1%
Gross margin
24.5%
Net margin
-26.8%
Operating margin
-26.4%
Efficiency
Return on assets
-19.9%
Return on equity
-42.2%
Return on invested capital
-53.8%
Return on capital employed
-26.9%
Return on sales
-24.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EVH stock price

How has the Evolent Health stock price performed over time
Intraday
0.83%
1 week
5.25%
1 month
4.57%
1 year
247.58%
YTD
21.21%
QTD
-3.81%

Financial performance

How have Evolent Health's revenue and profit performed over time
Revenue
$990.22M
Gross profit
$242.38M
Operating income
-$261.07M
Net income
-$265.3M
Gross margin
24.5%
Net margin
-26.8%
The net margin has increased by 30% YoY and by 18% QoQ
Evolent Health's net income has increased by 21% QoQ and by 21% YoY
EVH's gross profit is up by 21% year-on-year and by 4% since the previous quarter
The operating margin has increased by 20% YoY

Growth

What is Evolent Health's growth rate over time

Valuation

What is Evolent Health stock price valuation
P/E
N/A
P/B
2.71
P/S
1.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.77
The EPS rose by 25% YoY and by 24% QoQ
EVH's price to book (P/B) is 81% higher than its 5-year quarterly average of 1.5 and 43% higher than its last 4 quarters average of 1.9
The company's equity fell by 27% YoY
The price to sales (P/S) is 38% higher than the last 4 quarters average of 1.2 but 28% lower than the 5-year quarterly average of 2.3
The revenue has grown by 14% YoY but it has contracted by 3.2% from the previous quarter

Efficiency

How efficient is Evolent Health business performance
The ROS rose by 38% YoY and by 20% QoQ
The ROE has contracted by 27% YoY but it has grown by 13% from the previous quarter
Evolent Health's return on assets has increased by 18% QoQ and by 6% YoY
EVH's return on invested capital is up by 9% since the previous quarter

Dividends

What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EVH.

Financial health

How did Evolent Health financials performed over time
The company's total assets is 90% higher than its total liabilities
The quick ratio has grown by 17% YoY
The total liabilities has increased by 14% YoY but it has decreased by 8% from the previous quarter
The debt is 52% lower than the equity
The company's equity fell by 27% YoY
The debt has decreased by 18% YoY and by 18% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.